Zydus Cadila gets DCGI nod for hepatitis drug for Covid-19 treatment hi IndiaNational On Apr 23, 2021 BUY-SELL | HELP WANTED | MATRIMONIAL Drug firm Zydus Cadila on Friday said it has received restricted emergency use approval from the Indian drug regulator for the use of Pegylated Interferon alpha-2b (PegIFN) in treating moderate Covid-19 infection in adults. Continue ReadingReplica of Print on your device! Share